eNewsletter Sign-Up

Sorry, you must have JavaScript enabled to sign up for newsletters.

Biotechnologies Available for Licensing:
By Title

Available biotechnologies may also be viewed by type and application.

in vivo data availablein vivo data available

 

Title Tech ID #
Adenosine A2A Receptor:  A Prognosis Marker for Lung Cancer 08-11
Novel Phospholipid-Based TLR Inhibitors 07-07
Antibody against VGamma4 T Cells reduces Rheumatoid Arthritis symptoms in a mousein vivo data available 07-06
Knee aspirate facilitator 07-02
A novel histone demethylase and its 3-D structure 06-08
MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo in vivo data available  06-05
Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.) Invention Awarded a "Proof of Concept" Grant from the State of Colorado 04-08
Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseases 04-05
Be-Adducts and 10Be-Adduct Probes in the Diagnosis and Treatment of Disease 04-03
Method for identifying MHC-presented epitopes for T cells 03-01
Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancerin vivo data availableInvention Awarded a "Proof of Concept" Grant from the State of Colorado 02-16
Efficient method to produce mature neutrophils from embryonic stem cells 02-08
Liposomal clodronate as a therapy for autoimmune hemolytic anemiain vivo data available 02-07
High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway 02-05
Use of soluble gamma/delta T cell receptor as a therapy for inflammatory diseases and cancerin vivo data availableInvention Awarded a "Proof of Concept" Grant from the State of Colorado 02-03
Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsivenessin vivo data availableInvention Awarded a "Proof of Concept" Grant from the State of Colorado 01-01
Cdk6 as a marker for breast cancer 00-11
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs 00-05
Novel molecular targets for anti-inflammatory drug development:
- TALL-1: A member of the TNF gene family
- TALL-1 receptor (BCMA)
- TALL-1 and receptors 3D structure
00-01
Method for treating inflammatory diseases using heat shock proteinsin vivo data availableInvention Awarded a "Proof of Concept" Grant from the State of Colorado 98-07
Anti-CD79 antibody offers novel approach to therapy in autoimmune disease, transplantation and lymphomain vivo data available 98-04
Thioredoxins for the treatment of lung diseasein vivo data available 96-07
Method to Identify Compounds Regulating Actin Polymerization  96-06
Peptides offer strategies for novel immunosuppressants and anti-herpes agents 96-02
Promising gene immunotherapy technology fights tumors and infectious diseasesin vivo data available 95-03
Method for Targeting Antigens to Specific Presenting Cells Enhances Immune Regulation 95-01
Method to Produce Monoclonal Antibodies to Human T-Cell Receptor Elements 91-02

 

Research Tools

View list of available Antibodies or Animal models.

 

Biomedical Devices

View list of available biomedical devices.

 

For more information, contact Emmanuel Hilaire at [email protected].

Appointments


1-800-222-5864

Our Researchers


National Jewish Health attracts world-class researchers who conduct leading-edge scientific investigations.

Find a researcher.

Faculty by Research


The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our A-Z directory of Faculty by Area of Research.